These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 10671955)

  • 1. Metformin and ovarian steroidogenesis in PCOS women.
    De Leo V; La Marca A; Morgante G
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):243; author reply 244-6. PubMed ID: 10671955
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of metformin on insulin resistance and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Unlühizarci K; Keleştimur F; Bayram F; Sahin Y; Tutuş A
    Clin Endocrinol (Oxf); 1999 Aug; 51(2):231-6. PubMed ID: 10468995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin and polycystic ovary syndrome.
    Diamanti-Kandarakis E; Kouli C; Tsianateli T; Bergiele A
    Clin Endocrinol (Oxf); 2000 Feb; 52(2):243-6. PubMed ID: 10671954
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance.
    Ulloa-Aguirre A; Portocarrero L; Zariñán T; Olivares A; Carranza-Lira S; Veldhuis JD; López-Alvarenga JC
    Reprod Biomed Online; 2006 Jun; 12(6):669-83. PubMed ID: 16792841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of metformin supplementation during ovarian stimulation of lean PCOS patients undergoing in vitro fertilization.
    Kumbak B; Kahraman S
    Acta Obstet Gynecol Scand; 2009; 88(5):563-8. PubMed ID: 19306135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian steroidogenic response to human chorionic gonadotrophin in obese women with polycystic ovary syndrome: effect of metformin.
    Koivunen RM; Morin-Papunen LC; Ruokonen A; Tapanainen JS; Martikainen HK
    Hum Reprod; 2001 Dec; 16(12):2546-51. PubMed ID: 11726572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute effects of metformin therapy include improvement of insulin resistance and ovarian morphology.
    Bayrak A; Terbell H; Urwitz-Lane R; Mor E; Stanczyk FZ; Paulson RJ
    Fertil Steril; 2007 Apr; 87(4):870-5. PubMed ID: 17224152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of metformin treatment on luteal phase progesterone concentration in polycystic ovary syndrome.
    Meenakumari KJ; Agarwal S; Krishna A; Pandey LK
    Braz J Med Biol Res; 2004 Nov; 37(11):1637-44. PubMed ID: 15517078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum anti-Müllerian hormone levels remain high until late reproductive age and decrease during metformin therapy in women with polycystic ovary syndrome.
    Piltonen T; Morin-Papunen L; Koivunen R; Perheentupa A; Ruokonen A; Tapanainen JS
    Hum Reprod; 2005 Jul; 20(7):1820-6. PubMed ID: 15802325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of long-term metformin treatment on adrenal and ovarian steroidogenesis in women with polycystic ovary syndrome.
    Vrbíková J; Hill M; Stárka L; Cibula D; Bendlová B; Vondra K; Sulcová J; Snajderová M
    Eur J Endocrinol; 2001 Jun; 144(6):619-28. PubMed ID: 11375796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin therapy in women with polycystic ovary syndrome.
    Aruna J; Mittal S; Kumar S; Misra R; Dadhwal V; Vimala N
    Int J Gynaecol Obstet; 2004 Dec; 87(3):237-41. PubMed ID: 15548396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Obese patients with polycystic ovary syndrome: evidence that metformin does not restore sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by ovarian steroids.
    Eagleson CA; Bellows AB; Hu K; Gingrich MB; Marshall JC
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5158-62. PubMed ID: 14602743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian responses to hCG stimulation: insulin resistance/hyperinsulinaemia vs. insulin deficiency.
    Witchel SF; Arslanian S
    Clin Endocrinol (Oxf); 1999 Jul; 51(1):127-30. PubMed ID: 10468975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gonadotropin-releasing hormone antagonist and metformin for treatment of polycystic ovary syndrome patients undergoing in vitro fertilization-embryo transfer.
    Doldi N; Persico P; Di Sebastiano F; Marsiglio E; Ferrari A
    Gynecol Endocrinol; 2006 May; 22(5):235-8. PubMed ID: 16785142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Metformin for the treatment of polycystic ovary syndrome].
    Gundelach T; Rodewald M; Bekes I; Janni W; Hancke K
    Med Monatsschr Pharm; 2016 Feb; 39(2):75-8. PubMed ID: 26983336
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Polycystic ovary syndrome: treatment with insulin-sensitizing agents].
    Laboureau-Soares Barbosa S; Rodien P; Rohmer V
    Ann Endocrinol (Paris); 2002 Feb; 63(1):31-5. PubMed ID: 11937980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin versus metformin plus rosiglitazone in women with polycystic ovary syndrome.
    Liao L; Tian YJ; Zhao JJ; Xin Y; Xing HY; Dong JJ
    Chin Med J (Engl); 2011 Mar; 124(5):714-8. PubMed ID: 21518564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical, metabolic and endocrine parameters in response to metformin in obese women with polycystic ovary syndrome: a randomized, double-blind and placebo-controlled trial.
    Chou KH; von Eye Corleta H; Capp E; Spritzer PM
    Horm Metab Res; 2003 Feb; 35(2):86-91. PubMed ID: 12734787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.